IMBiotechnologies

IMBiotechnologies Ltd. is a private medical device company based in Canada, focusing on the commercialization of medical products in the field of embolic therapy. IMB's mission is to create and commercialize innovative products that treat human diseases and improve quality of life.IMB’s core technology is developed for the treatment of solid malignant tumors as well as benign tumors or hypertrophic/hyperplastic tissues. Examples include: Solid malignant tumors: Liver cancer (hepatocellular carcinoma or liver cancer), kidney cancer (renal cell carcinoma or renal cell cancer); Benign tumors: Uterine fibroids, hemangiomas, benign prostatic hyperplasia/hypertrophy (BPH).